Houston, TX - May 25, 2016 – CRG, a healthcare-focused investment firm delivering pioneering growth capital solutions to the global healthcare market, announced today that David Carter has been promoted to Managing Director.
Mr. Carter joined the firm in 2003 and previously served as a Principal. Mr. Carter’s responsibilities include identifying, structuring, and leading due diligence related to new financing transactions, monitoring existing investments, and managing the firm’s junior investment team members. During his tenure at CRG, Mr. Carter has been directly involved in over 30 investments, representing more than $1.5 billion of committed capital.
“David’s diligence expertise and extensive industry relationships have been integral to CRG’s success and investment performance to date. This promotion reflects his past achievements as well as our expectations for his continued leadership as a senior member of the management team,” said Charles W. Tate, Founding Partner and Chairman of CRG.
"David’s knowledge of our industry and CRG’s business model makes him an invaluable asset to the Firm. We are proud and delighted to promote him to fill this role, and I know he will continue to be a strong contributor to the execution of our global growth strategy,” added Nate Hukill, President of CRG.
Prior to joining CRG, Mr. Carter was a Partner at Palestra Capital, a New York-based hedge fund, where he focused on risk arbitrage, special situations, and distressed securities. Before joining Palestra in 1999, Mr. Carter was a High Yield Analyst at Furman Selz LLC (acquired by ING Barings), where he was responsible for coverage of healthcare-related high yield debt. Previously, Mr. Carter was an investment banking analyst in the Healthcare Group at Chemical Bank and a research assistant in the Mergers & Acquisitions Group of Morgan Stanley. Mr. Carter received a Bachelor of Science in finance from The Pennsylvania State University in 1988. He received a Master of Arts degree in information science and systems in 1994 and an M.B.A. in 1996, both from Columbia University.
Founded in 2003, CRG (previously known as Capital Royalty L.P.) is a healthcare-focused investment firm that delivers pioneering growth capital financing solutions to the global healthcare industry. With over $2.5 billion of assets under management across 40 healthcare investments, CRG provides growth capital to healthcare companies primarily through structured debt and senior secured loans. CRG works across the spectrum of healthcare products, technologies and services and targets investment sizes ranging between $20 million and $300 million. The firm partners with innovative, commercial-stage healthcare companies that address large, unmet medical needs who are seeking flexible financing solutions with a committed, value-add partner to achieve their growth objectives. CRG is headquartered in Houston, Texas with offices in Boulder, Colorado and New York, New York. Please visit us at www.crglp.com.